Nasdaq Suspends Trading of Charming Medical
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 26 2025
0mins
Trading Halt Announcement: The Nasdaq Stock Market has halted trading in Charming Medical due to a request for additional information from the company.
Previous Trading Suspension: The Securities and Exchange Commission previously suspended trading in MCTA from November 12, 2025, to November 25, 2025.
Last Sale Price: The last recorded sale price of Charming Medical's ordinary shares was $29.355.
Regulatory Oversight: The actions taken by the Nasdaq and the SEC highlight ongoing regulatory scrutiny in the stock market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
